2Noris P, Spedini P, Belletti S, et al. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly) : clinical and laboratory findings. Am J Med, 1998, 104 : 355-360.
3Greinacher A, Mueller-Eckhardt C. Hereditary types of thrombocytopenia with giant platelets and inclusion bodies in the leukocytes. Blut, 1990, 60:53-60.
4Field D, Taube E, Heumann S. Performance evaluation of the immature granulocyte parameter on the Sysmex XE-2100 automated hematology analyzer. Lab Hematol,2006,12 : 11-14.
5Lusher JM, Schneider J, Mizukami I, et al. The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies. Blood, 1968, 32:950-961.
6Siddiqui T. Ultrastructure of the May-Hegglin anomaly. J Pak Med Assoc, 1997,47 : 224 -226.
7Klug H, lhle E, Baudach A, et al. The ultrastructure of megathmmbocytes in May-Hegglin's anomaly. Folia Haematol Int Mag Klin Morphol Blufforsch, 1982,109:278-289.
8Tsoi WC, Yuen PM, Tsang SS, et al. A morphologic variant of May-Hegglin anomaly in a Chinese girl. Pathology, 1994,26:53- 55.
9Kunishima S, Matsushita T, Kojima T, et al. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest,2003,83 : 115-122.
10Kunishima S, Kojima T, Tanaka T, et al. Mapping of a gene for May-Hegglin anomaly to chromosome 22q. Hum Genet, 1999,105: 379-383.
1Sirachainan N, Komwilaisak P, Kitamura K, et al. The first two of MYH9 disorders in Thailand: an international collaborative study[J]. Ann Hematol, 2015, 94(4):707-709.
2Landi D, Lockhart E, Miller SE, et al. Report of a young girl with MYH9 mutation and review of the literature[J]. J Pediatr Hematol Oncol, 2012, 34(7):538-540.
3Eiehel Y, Tormos LM, Squires JE. Preoperative use of platelets in a 6-year-old with acute appendicitis and a myosin heavy ehain 9 - related disorder: a case report and review of literature[J]. Transfusion, 2016, 56(2):349-353.
4Hao J, Kunishima S, Guo X, et al. A large family with MYH9 disorder caused by E1841 K mutation suffering from serious kidney and hearing impairment and cataracts[J]. Ann Hematol, 2012, 91(7):1147-1148.
5Pecci A, Verver E J, Schlegel N, et al. Cochlear implantation is safe and effective in patients with MYH9-related disease[J]. Orphanet J Rare Dis, 2014, 9:100.
6Fatima S. May-Hegglin anomaly: rare entity with review of literature[J]. Indian J Hematol Blood Transfus, 2012, 28(1):58-60.
7Hussein BA, Gomez K, Kadir RA. May-Hegglin anomaly and pregnancy: a systematic review[J]. Blood Coagul Fibrinolysis, 2013, 24(5):554-561.
8Ruhoy SM, Yates A. Macrothrombocytopenia with dohle body- like granulocyte inclusions: a case report of May-Hegglin anomaly in a 33-year-old white woman with an update on the molecular findings of MYH9-related disease[J]. Lab Med, 2016, 47(3): 246- 250.
9张之南.血液病诊断及疗效标准[M],2版.北京:人民卫生出版社,2011:9.
10Garcfa Vallejo G, Cabellos M, Kabiri M, et al. Anaesthetic implications in a pregnant patient with an extreme thrombocytopenia due to a May-Hegglin anomaly: general o regional anaesthesia?[J]. Rev Esp Anestesiol Reanim, 2014, 61(8): 460-465.
